MOLOGEN AG Inactive Instrument
Mologen AG Stock Deutsche Boerse AG
Equities
DE0006637200
Biotechnology & Medical Research
More news
| Members of the board | Title | Age | Since |
|---|---|---|---|
Wenhai Wang
BRD | Director/Board Member | 70 | - |
Frank Pauly
BRD | Director/Board Member | - | - |
| Director/Board Member | - | - |
Mologen AG is a Germany-based company engaged in the biotechnology and medical research industry. The Company specializes in the research and development of drugs in the fields of oncology and infectious diseases. The Company develops medicines and vaccines on the basis of its MIDGE, dSLIM and EnanDIM platform technologies and through the use of its human, allogeneic tumor cell bank. Within the area of oncology, the Company develops Lefitolimod, which is intended to enable the patient's immune system to recognize the body's own cancer cells and fight them, MGN1601, which works like a therapeutic vaccination against cancer, as well as MGN1404, which is targeted at malignant melanoma. Within the area of infectious diseases, the Company develops deoxyribonucleic acid (DNA) vaccines against leishmaniasis and hepatitis B.
| 1st Jan change | Capi. | |
|---|---|---|
| +2.13% | 42.11B | |
| +48.83% | 40.08B | |
| +8.07% | 40B | |
| -10.82% | 26.87B | |
| +7.54% | 24.58B | |
| -23.87% | 18.44B | |
| +1.33% | 11.94B | |
| +31.23% | 11.66B | |
| +7.34% | 11.01B |
